Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0149962001
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Approved | 02550857 | LUPIN PHARMA CANADA LIMITED | ARMLUPEG | Human | Yes | Schedule D | 1 | PEGFILGRASTIM | 6 MG / 0.6 ML |
Approved | 02550857 | LUPIN PHARMA CANADA LIMITED | ARMLUPEG | Human | Yes | Prescription | 1 | PEGFILGRASTIM | 6 MG / 0.6 ML |
Marketed | 02484153 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | FULPHILA | Human | Yes | Schedule D | 1 | PEGFILGRASTIM | 10 MG / ML |
Marketed | 02484153 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | FULPHILA | Human | Yes | Prescription | 1 | PEGFILGRASTIM | 10 MG / ML |
Marketed | 02474565 | APOTEX INC | LAPELGA | Human | Yes | Schedule D | 1 | PEGFILGRASTIM | 6 MG / 0.6 ML |
Marketed | 02474565 | APOTEX INC | LAPELGA | Human | Yes | Prescription | 1 | PEGFILGRASTIM | 6 MG / 0.6 ML |
Marketed | 02529343 | APOTEX INC | LAPELGA | Human | Yes | Schedule D | 1 | PEGFILGRASTIM | 6 MG / 0.6 ML |
Marketed | 02529343 | APOTEX INC | LAPELGA | Human | Yes | Prescription | 1 | PEGFILGRASTIM | 6 MG / 0.6 ML |
Marketed | 02249790 | AMGEN CANADA INC | NEULASTA | Human | Yes | Schedule D | 1 | PEGFILGRASTIM | 10 MG / ML |
Marketed | 02249790 | AMGEN CANADA INC | NEULASTA | Human | Yes | Prescription | 1 | PEGFILGRASTIM | 10 MG / ML |
Approved | 02546973 | NORA PHARMA INC | NIOPEG | Human | Yes | Schedule D | 1 | PEGFILGRASTIM | 6 MG / 0.6 ML |
Approved | 02546973 | NORA PHARMA INC | NIOPEG | Human | Yes | Prescription | 1 | PEGFILGRASTIM | 6 MG / 0.6 ML |
Marketed | 02506238 | PFIZER CANADA ULC | NYVEPRIA | Human | Yes | Prescription | 1 | PEGFILGRASTIM | 6 MG / 0.6 ML |
Marketed | 02506238 | PFIZER CANADA ULC | NYVEPRIA | Human | Yes | Schedule D | 1 | PEGFILGRASTIM | 6 MG / 0.6 ML |
Marketed | 02497395 | SANDOZ CANADA INCORPORATED | ZIEXTENZO | Human | Yes | Prescription | 1 | PEGFILGRASTIM | 6 MG / 0.6 ML |
Marketed | 02497395 | SANDOZ CANADA INCORPORATED | ZIEXTENZO | Human | Yes | Schedule D | 1 | PEGFILGRASTIM | 6 MG / 0.6 ML |
Application information
Related information
Contact us
Version 4.0.3